Columnists
Tipsheet
Cartoons
Podcasts
Newsletters
Sections
Podcasts
Townhall TV
Election
Capitol Voices
Entertainment
Radio News
Live Blog
Topics
Sites
Hot Air
PJ Media
Bearing Arms
Twitchy
RedState
JOIN VIP
LOGIN
MY ACCOUNT
Account Settings
Newsletter Subscriptions
Log Out
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Articles published by Gyre Therapeutics, Inc.
Gyre Therapeutics Reports Third Quarter 2024 and Year-To-Date Financial Results and Provides Business Update
November 13, 2024
From
Gyre Therapeutics, Inc.
Via
GlobeNewswire
Tickers
GYRE
Gyre Therapeutics Announces Last Patient Completed Pivotal Phase 3 Trial Evaluating F351 for CHB-Associated Liver Fibrosis
October 22, 2024
From
Gyre Therapeutics, Inc.
Via
GlobeNewswire
Tickers
GYRE
Gyre Therapeutics to Present at 8th Annual H.C. Wainwright MASH Investor Conference
October 01, 2024
From
Gyre Therapeutics, Inc.
Via
GlobeNewswire
Tickers
GYRE
Gyre Therapeutics to Present at H.C. Wainwright 26th Annual Global Investment Conference
September 04, 2024
From
Gyre Therapeutics, Inc.
Via
GlobeNewswire
Tickers
GYRE
Gyre Therapeutics Reports Second Quarter 2024 and Year-To-Date Financial Results and Provides Business Update
August 13, 2024
From
Gyre Therapeutics, Inc.
Via
GlobeNewswire
Tickers
GYRE
Gyre Therapeutics to Present at Sidoti Virtual Investor Conference
August 09, 2024
From
Gyre Therapeutics, Inc.
Via
GlobeNewswire
Tickers
GYRE
Gyre Therapeutics Announces Appointment of David M. Epstein, Ph.D., to Board of Directors
August 08, 2024
From
Gyre Therapeutics, Inc.
Via
GlobeNewswire
Tickers
BDTX
GYRE
Gyre Therapeutics Announces China’s NMPA Approval of Avatrombopag Maleate Tablets for the Treatment of CLD-Associated Thrombocytopenia
July 02, 2024
From
Gyre Therapeutics, Inc.
Via
GlobeNewswire
Tickers
GYRE
Gyre Therapeutics Announces Publication in Journal of Gastroenterology and Hepatology
June 18, 2024
From
Gyre Therapeutics, Inc.
Via
GlobeNewswire
Tickers
GYRE
Gyre Pharmaceuticals Receives IND Approval from China’s NMPA to Evaluate F230 for the Treatment of Pulmonary Arterial Hypertension
May 30, 2024
From
Gyre Therapeutics, Inc.
Via
GlobeNewswire
Tickers
GYRE
Gyre Therapeutics Announces Expected Addition to the Russell 2000® and Russell 3000® Indexes
May 28, 2024
From
Gyre Therapeutics, Inc.
Via
GlobeNewswire
Tickers
GYRE
Gyre Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update
May 09, 2024
From
Gyre Therapeutics, Inc.
Via
GlobeNewswire
Tickers
GYRE
Gyre Therapeutics Reports Full Year 2023 Financial Results and Provides Business Update
March 26, 2024
From
Gyre Therapeutics, Inc.
Via
GlobeNewswire
Tickers
GYRE
Gyre Therapeutics Expands Board of Directors with Appointment of Rodney L. Nussbaum
March 21, 2024
From
Gyre Therapeutics, Inc.
Via
GlobeNewswire
Tickers
GYRE
Gyre Therapeutics Presents Poster at the American Association for the Study of Liver Diseases (AASLD) Annual Liver Meeting
November 13, 2023
From
Gyre Therapeutics, Inc.
Via
GlobeNewswire
Tickers
GYRE
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.